Editorial comment to therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma.
Alain
A
Ravaud
D000970:Antineoplastic Agents / Q000009:adverse effects*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D002318:Cardiovascular Diseases / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents